Ledger.Open graph →
SEC Form D · filed November 12, 2020

Adagio Therapeutics, Inc

Offering
$49.9M
Sold
$49.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Marc G. Elia · WALTHAM, MADirectorPhilip T. Chase · WALTHAM, MADirectorRene G. Russo · WALTHAM, MADirectorHoward G. Mayer · WALTHAM, MADirectorTillman U. Gerngross · WALTHAM, MAExec · DirectorHalley G. Gilbert · WALTHAM, MAExecAjay T. Royan · WALTHAM, MADirectorTerrance G. Mcguire · WALTHAM, MADirectorBen Taylor · Nicholasville, KYDirectorFrank C. Taylor · Nicholasville, KYDirectorChatrasingh K. Joyram · Henrietta, O4DirectorSteve Kirby · SIOUX FALLS, SDExecMark C. Taylor · Nicholasville, KYExec · DirectorGordonMD PE Fund GP LLC · Beverly Hills, CADirectorElisa Zhang · Cedar City, UTDirectorGordonMD Global Investments LP · Beverly Hills, CADirectorKenney Oh · NEW YORK, NYExecLuther Williams · NEW YORK, NYDirectorGeorge W. Fisette · Charleston, SCDirectorJulie Castle · Porterville, CADirectorAlbert Berra · Porterville, CADirectorLynda Scearcy · Porterville, CADirectorMorris Tharp · Porterville, CADirectorJames Holly · Porterville, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗